The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Systems biology-based assessment of immune responses to whole cell and acellular pertussis vaccines
Open accessPublished version of a preprint
Abstract
Given the local and systemic adverse reactions associated with whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids (DTP), acellular pertussis vaccines combined with the same toxoids (DTaP) were developed in the 1990s. In comparison to DTP, DTaP vaccines demonstrated reduced reactogenicity and equivalent or improved immunogenicity and efficacy. However, there has been a resurgence of pertussis disease, particularly in DTaP-vaccinated children, suggesting that immunity wanes more quickly with DTaP vaccination. To elucidate the differences in immune responses to DTP and DTaP vaccines, we employed a systems biology-based strategy to compare global changes in gene expression following primary vaccination with either DTP or DTaP. We used RNA-Seq and ribosome profiling (RP) to identify transcriptional and translational signatures, respectively, in peripheral blood mononuclear cells (PBMCs) collected from 50 infant recipients of DTP or DTaP at two time-points (baseline (pre-vaccination at Day 1) and either Day 2 or 8 post-vaccination). We also used standard serologic methods to assess immunogenicity, and correlated these results with transcriptional and translational signatures. Here, we provide a detailed description of the rationale, experimental design, methodology, and enrollment procedures used. Given the technical complexity of our approach, our objective is to fill knowledge gaps, describe key quality metrics, and support future publications. In brief, we recovered 4-12 million PBMCs (average 8.9 million) with 99% viability per 2.5 mL blood sample, enabling excellent nucleic acid recovery yields for the preparation of high-quality sequencing libraries. In turn, these generated RNA-Seq and RP datasets with sufficient genome coverage breadth and depth to enable differential gene expression analyses, demonstrating the validity of this approach to study pertussis vaccine immunology specifically, and its utility to characterize mechanisms of the human immune response to vaccination generally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1×
“In mammals, translational ef fi ciency is the single bestpredictorofproteinlevels,asmRNAabundancealonecanonlyaccount for~40%ofthevariabilityobserved 17 , which is also subject to a broad dynamic range of up to 10-fold 18 .”
Translation inhibitors cause abnormalities in ribosome profiling experiments
Gerashchenko, M. V., & Gladyshev, V. N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku671 · Cited by 262
Flagged first, then by citations
Research works printed but not linked: 26
- Edwards, K. M. Pertussis Vaccines, in Vaccines, O. W. A. Plotkin S. A., Offit P. A., Editor. Sixth edition. edn, (Elsevier Saunders, 2013).
- Decker, M. D. et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 96, 557–566 (1995). · DOI
- Edwards, K. M. et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96, 548–557 (1995). · DOI
- Klein, N. P., Bartlett, J., Rowhani-Rahbar, A., Fireman, B. & Baxter, R. Waning protection after fifth dose of acellular pertussis vaccine in children. N. Engl. J. Med. 367, 1012–1019 (2012). · DOI
- Witt, M. A., Katz, P. H. & Witt, D. J. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin. Infect. Dis. 54, 1730–1735 (2012). · DOI
- Sheridan, S. L., Ware, R. S., Grimwood, K. & Lambert, S. B. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 308, 454–456 (2012). · DOI
- Liko, J., Robison, S. G. & Cieslak, P. R. Priming with whole-cell versus acellular pertussis vaccine. N. Engl. J. Med 368, 581–582 (2013). · DOI
- Warfel, J. M., Zimmerman, L. I. & Merkel, T. J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc. Natl Acad. Sci. USA 111, 787–792 (2014). · DOI · Paper page
- Pulendran, B. Systems vaccinology: probing humanity’s diverse immune systems with vaccines. Proc. Natl Acad. Sci. USA 111, 12300–12306 (2014). · DOI
- Ingolia, N. T. Ribosome profiling: new views of translation, from single codons to genome scale. Nat. Rev. Genet. 15, 205–213 (2014). · DOI
- Ingolia, N. T., Brar, G. A., Rouskin, S., McGeachy, A. M. & Weissman, J. S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat. Protoc. 7, 1534–1550 (2012). · DOI
- Brar, G. A. & Weissman, J. S. Ribosome profiling reveals the what, when, where and how of protein synthesis. Nat. Rev. Mol. Cell Biol. 16, 651–664 (2015). · DOI
- Edwards, K. M. Review of the laboratory approaches to the detection of antibody and cell-mediated immunity to pertussis disease and vaccine. Expert Rev. Vaccines 13, 1183–1190 (2014). · DOI
- Edwards, K. M. & Berbers, G. A. Immune responses to pertussis vaccines and disease. J. Infect. Dis. 209, S10–S15 (2014). · DOI
- Creech, C. B. et al. Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccines. npj Vaccines https://doi.org/10.1038/s41541-025-01170-5 (2025). · DOI
- Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. & Weissman, J. S. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324, 218–223 (2009). · DOI · Paper page
- Ingolia, N. T., Lareau, L. F. & Weissman, J. S. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147, 789–802 (2011). · DOI · Paper page
- Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell Proteom. 13, 397–406 (2014). · DOI · Paper page
- Prensner, J. R. et al. What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome? Mol. Cell Proteom. 22, 100631 (2023). · DOI
- Duncan, C. D. S. & Mata, J. Effects of cycloheximide on the interpretation of ribosome profiling experiments in Schizosaccharomyces pombe. Sci. Rep. 7, 10331 (2017). · DOI
- Sharma, P., Wu, J., Nilges, B. S. & Leidel, S. A. Humans and other commonly used model organisms are resistant to cycloheximide-mediated biases in ribosome profiling experiments. Nat. Commun. 12, 5094 (2021). · DOI
- Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–840 (2010). · DOI · Paper page
- Kleiveland, C. R. in The Impact of Food Bioactives on Health: in vitro and ex vivo models (eds K. Verhoeckx et al.) 161–167 (Springer Copyright 2015, The Author(s) 2015). · DOI · Paper page
- Slade, H. B. et al. Flow cytometric analysis of lymphocyte subpopulations in infants with congenital heart disease. J. Clin. Lab. Anal. 3, 14–20 (1989). · DOI
- Kutvirt, S. G., Lewis, S. L. & Simon, T. L. Lymphocyte phenotypes in infants are altered by separation of blood on density gradients. Br. J. Biomed. Sci. 50, 321–328 (1993).
- Vila-Sanjurjo, A., Juarez, D., Loyola, S., Torres, M. & Leguia, M. Minority gene expression profiling: probing the genetic signatures of pathogenesis using ribosome profiling. J. Infect. Dis. 221, S341–S357 (2020). · DOI
Metadata
- Authors
- Leguia, M., Vila-Sanjurjo, A., Juarez, D., Garcia-Glaessner, A., Gil, A. I., Alvarez, M., Cornejo, R., Cherikh, S., Gelber, C. E., Goll, J. B., Howard, L. M., Jimenez-Truque, N., Edwards, K. M., Creech, C. B., & Lanata, C. F.
- Affiliations
- Pontificia Universidad Católica del Perú (PE)
- Instituto de Investigación Nutricional (PE)
- Emmes (United States) (US)
- Vanderbilt University Medical Center (US)
- ORCID
- Venue
- npj Vaccines
- Published
- 2025-08-11
- Volume
- 10
- Issue
- 1
- Pages
- 188-188
- ISSN
- 2059-0105 (ISSN-L)
- PMC
- PMC12340147
- OpenAlex
- W4413106949
- Cited by
- 1
- References
- 2
- Citations by year
- 2025: 1
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- npj Vaccines (publishedVersion, cc-by-nc-nd)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- NIH-NIAID (HSN2722001300023I, Task Order 17)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Diphtheria, Corynebacterium, and Tetanus
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- pertussis vaccine, DTaP vaccine, DTP vaccine, whole-cell pertussis vaccine, acellular pertussis vaccine, vaccine immunogenicity, vaccine response, peripheral blood mononuclear cells, gene expression signatures, ribosome profiling, infant immunization, waning immunity, pertussis resurgence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
